4 studies found for:    15118125 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)
Condition: Lung Cancer
Interventions: Drug: Erlotinib;   Drug: Bevacizumab
2 Unknown  Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: erlotinib;   Procedure: FDG-/FLT-PET
3 Withdrawn A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Intervention: Drug: BIBW 2992 (Afatinib)
4 Active, not recruiting Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung
Conditions: Adenocarcinoma;   Non-small Cell Lung Cancer
Intervention: Drug: Erlotinib

Indicates status has not been verified in more than two years